Total Debt
$96.5M
Net Debt
-$104.4M
ARS Pharmaceuticals, Inc. currently has $96.5M in total debt. Net debt is -$104.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
SPRY • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.10 | 0.20 | -0.10Net Cash | 0.29 | 33.6% |
| 2025-12-31 | 0.10 | 0.24 | -0.15Net Cash | 0.33 | 29.4% |
| 2025-09-30 | 0.00 | 0.29 | -0.29Net Cash | 0.37 | 0.4% |
| 2025-06-30 | 0.00 | 0.24 | -0.24Net Cash | 0.31 | 0.5% |
| 2025-03-31 | 0.00 | 0.28 | -0.28Net Cash | 0.33 | 0.0% |
| 2024-12-31 | 0.00 | 0.31 | -0.31Net Cash | 0.35 | 0.0% |
| 2024-09-30 | 0.00 | 0.20 | -0.20Net Cash | 0.22 | 0.0% |
| 2024-06-30 | 0.00 | 0.22 | -0.22Net Cash | 0.22 | 0.1% |
| 2024-03-31 | 0.00 | 0.22 | -0.22Net Cash | 0.23 | 0.1% |
| 2023-12-31 | 0.00 | 0.23 | -0.23Net Cash | 0.23 | 0.1% |
| 2023-09-30 | 0.00 | 0.24 | -0.24Net Cash | 0.25 | 0.1% |
| 2023-06-30 | 0.00 | 0.25 | -0.25Net Cash | 0.26 | 0.1% |
| 2023-03-31 | 0.00 | 0.26 | -0.26Net Cash | 0.27 | 0.2% |
| 2022-12-31 | 0.00 | 0.27 | -0.27Net Cash | 0.28 | 0.2% |
| 2022-09-30 | 0.01 | 0.04 | -0.03Net Cash | 0.04 | 15.9% |
| 2022-06-30 | 0.01 | 0.04 | -0.04Net Cash | 0.05 | 15.7% |
| 2022-03-31 | 0.01 | 0.25 | -0.25Net Cash | 0.31 | 1.8% |
| 2021-12-31 | 0.01 | 0.06 | -0.05Net Cash | 0.06 | 14.7% |
| 2021-09-30 | 0.01 | 0.30 | -0.29Net Cash | 0.35 | 1.8% |
| 2021-06-30 | 0.00 | 0.36 | -0.36Net Cash | 0.37 | 0.7% |
| 2021-03-31 | 0.00 | 0.37 | -0.37Net Cash | 0.38 | 0.9% |
| 2020-12-31 | 0.00 | 0.39 | -0.38Net Cash | 0.39 | 1.0% |
| 2019-12-31 | 0.02 | 0.01 | 0.01 | 0.02 | 99.8% |